Herve Delacour Sofya Lushchekina Isabelle Mabboux Aurore Bousquet Franck Ceppa Lawrence M Schopfer Oksana Lockridge Patrick Masson
10.1371/journal.pone.0101552
PLoS One
2014 Jul 23;9(7):e101552.
CC0
https://pubmed.ncbi.nlm.nih.gov/25054547/
Apnea / chemically induced Butyrylcholinesterase / genetics Mutation, Missense Neuromuscular Depolarizing Agents / adverse effects
Apnea / chemically induced Butyrylcholinesterase / genetics Mutation, Missense Neuromuscular Depolarizing Agents / adverse effects Case Reports Research Support, Non-U.S. Gov't Alleles Apnea / enzymology Apnea / genetics Base Sequence Biocatalysis Butyrylcholinesterase / chemistry Butyrylcholinesterase / metabolism DNA Mutational Analysis Family Health Female Humans Infant, Newborn Isoquinolines / adverse effects Kinetics Male Mivacurium Molecular Dynamics Simulation Pedigree Succinylcholine / adverse effects Isoquinolines Neuromuscular Depolarizing Agents Mivacurium Butyrylcholinesterase Succinylcholine
PMC4108472
25054547
Characterization of a novel BCHE "silent" allele: point mutation (p.Val204Asp) causes loss of activity and prolonged apnea with suxamethonium
2014